(Q45975657)

http://europepmc.org/abstract/MED/27539689

18 December 2017

title

Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Scott D Berkowitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Keith Fox

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

11

Daniel E Singer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

author name string

Matthew W Sherwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Derek D Cyr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

W Schuyler Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Richard C Becker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Jeffrey B Washam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Christopher C Nessel

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Manesh R Patel

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Günter Breithardt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Jonathan L Halperin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Jonathan P Piccini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

Kenneth W Mahaffey

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

publication date

1 August 2016

1 reference

http://europepmc.org/abstract/MED/27539689

18 December 2017

published in

JACC: Cardiovascular Interventions

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

page(s)

1694-1702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study

13 May 2020

cites work

1 reference

12 December 2020

Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents

1 reference

12 December 2020

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

1 reference

12 December 2020

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

1 reference

12 December 2020

Ischemic stroke after acute myocardial infarction. A population-based study

1 reference

12 December 2020

Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions

1 reference

12 December 2020

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

1 reference

12 December 2020

Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

1 reference

12 December 2020

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

1 reference

12 December 2020

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

1 reference

12 December 2020

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary.

1 reference

12 December 2020

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorse

1 reference

12 December 2020

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Atrial fibrillation and the risk of myocardial infarction

1 reference

12 December 2020

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

12 December 2020

Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial

1 reference

12 December 2020

Rivaroxaban in patients with a recent acute coronary syndrome

1 reference

12 December 2020

Edoxaban versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

1 reference

12 December 2020

Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population

1 reference

12 December 2020

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

1 reference

12 December 2020

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

1 reference

12 December 2020

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

1 reference

12 December 2020

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

1 reference

12 December 2020

Apixaban with antiplatelet therapy after acute coronary syndrome

1 reference

12 December 2020

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary interv

1 reference

12 December 2020

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1016/J.JCIN.2016.05.039

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6921699&resulttype=core&format=json

13 May 2020

1 reference